Blog
RSS FeedPosted by Michael Wonder on 06 Aug 2018
Duncan Garner's desperate plea to Jacinda Ardern over cancer funding
7 August 2018 - "There are people dying, mums and dads and brothers and sisters." ...
Posted by Michael Wonder on 06 Aug 2018
Supply of anti-retroviral treatments
6 August 2018 - PHARMAC invites tenders for the supply of certain antiretroviral treatments to DHB hospitals and to community pharmacies ...
Posted by Michael Wonder on 03 Aug 2018
Visiting patient advocates say New Zealand isn’t treating its cancer patients fairly
3 August 2018 - One of Australia’s top oncologists, Professor John Zalcberg, will be in New Zealand next week highlighting ...
Posted by Michael Wonder on 01 Aug 2018
Free access plan for 'revolutionary' drug that could eliminate Hepatitis C by 2030
1 August 2018 - What has been called a "revolutionary" hepatitis C drug could soon be available free-of-charge to all ...
Posted by Michael Wonder on 01 Aug 2018
Steve Maharey appointed as PHARMAC chairman
1 August 2018 - A former Labour cabinet minister has been installed as the chairman of the drug-buying agency PHARMAC, ...
Posted by Michael Wonder on 31 Jul 2018
New Zealand Pharmaceutical Schedule - 1 August 2018 update
1 August 2018 - The August 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Jul 2018
Julia McNicol doesn't have enough cancer to get the drugs she needs to fight it
30 July 2018 - Julia McNicol has a rare and aggressive skin cancer, but can't access public funding for the ...
Posted by Michael Wonder on 29 Jul 2018
PTAC defers submission for new indication for PD-L1 antagonist
27 July 2018 - This time its for patients with Hodgkin's disease. The reason; PTAC wants to see updated data ...
Posted by Michael Wonder on 26 Jul 2018
PTAC recommends immune checkpoint inhibitors for certain patients with advanced urothelial carcinoma
25 July 2018 - The publication of the minutes of the May 2018 PTAC meeting reveals new outcomes. ...
Posted by Michael Wonder on 23 Jul 2018
The man who should be four years dead
23 July 2018 - John Ashton had always wanted to see Cape Reinga. When he found out his time was running ...
Posted by Michael Wonder on 20 Jul 2018
Proposal to fund a pangenotypic hepatitis C treatment - glecaprevir and pibrentasvir (Maviret)
20 July 2018 - PHARMAC is seeking feedback on a proposal to fund a pangenotypic treatment for chronic hepatitis C ...
Posted by Michael Wonder on 19 Jul 2018
New Zealand to expand PHARMAC to the Pacific
19 July 2018 - New Zealand is looking at opening up access to its drug buying agency PHARMAC to five Pacific ...
Posted by Michael Wonder on 16 Jul 2018
PHARMAC work in funding medicines for rare disorders progressing
16 July 2018 - PHARMAC is progressing work aimed at improving funded access to medicines for rare disorders. ...
Posted by Michael Wonder on 12 Jul 2018
New Zealand’s medicines waiting list: international disgrace for patient equity
12 July 2018 - The medicines waiting list grows to over 100 priority medicines that wait to be publicly funded ...
Posted by Michael Wonder on 11 Jul 2018
Cannabis medication for kids with epilepsy can cost 'up to $100k'
11 July 2018 - Parents of children with severe epilepsy say the cost of marijuana-based medications is a barrier to potentially ...